Americas · General news · Toronto Star

Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

Published by Toronto Star · Canada 9 h ago

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both milestones attached to its backstop subscription commitment in ...

Read the full article on Toronto Star Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)

Also worth reading

Global News

‘Hurting’: Vigil in Wainwright, Alta., for soldiers caught in deadly fire

CBC News

U.S. envoy Witkoff meets with Putin in Russia amid report Musk throttled Starlink

CTV News

Canadian food banks see record-high 2.35 million visits each month: report

National Post

Ask Rebecca: My parents are leaving my broke brother more money than me. Is that fair?

France 24 Amériques

Midterms : une gauche plus radicale face à Donald trump ?

Le Devoir